Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

NCT07427576 · clinicaltrials.gov ↗

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Mite Allergy
Dermatophagoides Farinae Allergy
Dermatophagoides Pteronyssinus Allergy
Rhinitis, Allergic
Asthma
Rhinoconjunctivitis

Interventions

BIOLOGICAL: Clustoid® Max Forte

Sponsor

Inmunotek S.L.